Company news

Dr. Martens Plc (LSE:DOCS) news

Every Dr. Martens Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Dr. Martens Plc stock analysis →

Press releases & updates

Appointment of Independent Non-Executive Director

August 6, 2026

NED Appointment and Committee Changes

July 1, 2026

CEO share purchase

June 16, 2026

Admission to Trading

June 5, 2026

Directorate change

May 27, 2026

Dr Martens : FY26 transcript

May 20, 2026

FY26 Results

May 19, 2026

Appointment of Market General Managers

April 8, 2026

Total Voting Rights

February 27, 2026

EBT Share Purchase

January 29, 2026

Q3 FY26 Trading Statement

January 27, 2026

Holding(s) in Company

January 27, 2026

Director/PDMR Shareholding

January 15, 2026

Rezolve Ai Shatters Year-End Expectations: December Revenue Expected to Exceed $17 Million, ARR Expected to Exceed $200 Million

December 16, 2025

Block listing Interim Review

December 1, 2025

H1 FY26 Results

November 20, 2025

Gen Phoenix and Dr. Martens Celebrate Four Seasons of Waste Reduction with the Launch of the Solar Flare Collection

November 12, 2025

Appointment of joint corporate broker

October 10, 2025

UAE distribution partnership and LATAM expansion

October 2, 2025

Director/PCA Shareholding

September 2, 2025

Result of 2025 AGM

July 10, 2025

AGM Trading Update

July 10, 2025

Annual Financial Report

June 17, 2025

Final Results

June 5, 2025

Director Declaration

May 27, 2025

Appointment of Non-Executive Directors

February 12, 2025

Q3 FY25 Trading Statement

January 27, 2025

Block Listing Application

December 12, 2024

Confirmation of new CEO start date

November 28, 2024

Half-year Report

November 28, 2024

Transaction by PCA of PDMR

September 26, 2024

Result of AGM

July 11, 2024

Technical change in Permira ownership structure

June 12, 2024

Company Secretary Change

June 3, 2024

FY24 Results

May 30, 2024

CFO start date - update

May 10, 2024

FY24 trading and FY25 outlook update

April 16, 2024

CEO succession

April 16, 2024

CFO appointment update

February 27, 2024

Q3 FY24 Trading Statement

January 25, 2024

Transaction in Own Shares

December 15, 2023

Chief Brand Officer Appointment

November 16, 2023

CFO Appointment

November 14, 2023

Block listing application

November 2, 2023

Product and Brand teach-in event

September 14, 2023

Commencement of Share Buyback Programme

July 14, 2023

Trading Statement

July 13, 2023

Notification of transaction of PCA of PDMR

June 7, 2023

CFO retirement

April 14, 2023

Directorate Change

March 24, 2023

Older →